Health Trials

Refractory Idiopathic Membranous Nephropathy

1

Review clinical trials related to Refractory Idiopathic Membranous Nephropathy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Clinical Study of Anti-CD19/BCMA Universal Chimeric Antigen Receptor T Cells (UCAR-T) in the Treatment of Refractory Idiopathic Membranous Nephropathy (IMN)

A single arm, open-label pilot study is designed to determine the safety and effectiveness of anti-CD19/BCMA Universal Chimeric Antigen Receptor T Cells (UCAR-T) in the Treatment of Refractory Idiopathic Membranous Nephropathy (IMN)

Participants needed: 18
Trial details
Phase: Early Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital of Zhejiang Chinese Medical UniversityUpdated: Feb 20, 2026Locations: 1
Eligibility criteria

Aged 18 to 75 years inclusive, either gender; [+10]

Subjects with known allergic reaction, hypersensitivity, intolerance, or contrai... [+14]

Read more